Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes.
Related Posts
How a Company Makes Millions Off a Hospital Program Meant to Help the Poor
A private business has helped supercharge a controversial federal drug program. Patients and insurers have been left with big bills.
Your Top Health Questions of 2023, Answered
One thing I love about editing the Ask Well column is the camaraderie of it. Every week we answer a…
Contrary to Musk’s Claim, Ebola Containment Efforts Were Slowed Then Stopped, Former Officials Say
The contracts financed Ebola screening at airports and protective equipment for health workers, and helped prevent transmission by survivors of…